all report title image

PET DIABETES CARE DEVICES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Pet Diabetes Care Devices Market, By Animal Type (Dogs and Cats), By Solutions (Treatment (Insulin Therapy, Insulin Delivery Devices, Other Treatments), and Glucose Monitoring Devices), By End User (Veterinary Clinics, Home Care Settings, and Veterinary Hospitals), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

  • Published In : Aug 2024
  • Code : CMI7245
  • Pages :166
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

Market Concentration and Competitive Landscape

Pet Diabetes Care Devices Market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Rising incidence of diabetes

Along with awareness, the actual incidence of diabetes is rising rapidly in pets over the past decade. Certain breeds of dogs such as Poodles, Dachshunds and Terriers have a higher genetic risk for the disease. Even cats are quite prone to diabetes, especially older and obese felines. The core reasons attributed to increased diabetes cases are unhealthy pet diets, lack of exercise, and growing rates of obesity. Much like humans, pets too are victims of consuming low-quality commercial foods filled with carbohydrates, salts, and fats. Coupled with a sedentary lifestyle lacking physical activity, this has contributed substantially to weight gain issues across dog and cat populations. Excess weight is a major diabetes risk factor and the sizes of pet animals have ballooned over the years due to unhealthy dietary habits. While genetic predisposition cannot be altered, modifiable lifestyle factors associated with diabetes are well within control. With more owners now conscious about healthy pet nourishment and lifestyle maintenance, preventive approaches can help stem the diabetes tide. Still, the reality remains that more pets will require careful glucose management and advanced treatment solutions in the foreseen future. This growing diabetes patient pool indicates a marked need for innovative monitoring devices and therapies. Early diagnosis alongside consistent care ensures pets have the best outcomes and quality of lives despite the challenging disease. It also saves owners from the substantial costs involved with neglecting a diabetic pet's condition.

Key Players Insights
  • Abbot Laboratories, Inc
  • Virbac
  • Medtronic plc
  • Johnson & Johnson Services, Inc
  • Roche Diagnostics
  • Bio-Rad Laboratories, Inc
  • Novo Nordisk A/S
  • Zoetis Inc
  • Terumo Corporation
  • Boehringer Ingelheim International GmbH
  • IDEXX Laboratories
  • Johnson & Johnson Services, Inc
  • Terumo Corporation
  • Eli Lilly and Company
  • Vetoquinol S.A.
  • i-SENS, Inc.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2025 Coherent Market Insights Pvt Ltd. All Rights Reserved.